HIV reservoirs: What, where and how to target them

Nature Reviews Microbiology

Volumn 14, Issue 1, 2015, Pages 55-60

  Churchill, Melissa J ^a   Deeks, Steven G ^b   Margolis, David M ^c   Siliciano, Robert F ^d   Swanstrom, Ronald ^c  

^a BURNET INSTITUTE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTE; CD4+ T LYMPHOCYTE; CELL DIVISION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CYTOTOXIC T LYMPHOCYTE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REACTIVATION; VIRUS REPLICATION; ANIMAL MODEL; DRUG EFFECTS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; PHYSIOLOGY; PROVIRUS; VIROLOGY; VIRUS DNA CELL DNA INTERACTION; VIRUS LATENCY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; HIV; HIV INFECTIONS; HUMANS; MODELS, ANIMAL; PROVIRUSES; VIRUS INTEGRATION; VIRUS LATENCY;

EID: 84951567984     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2015.5     Document Type: Review

References (10)

1. Soriano-Sarabia, N. et al. Peripheral V-γ9Vδ2 T cells are a novel reservoir of latent HIV infection. PLoS Pathog. 11, e1005201 (2015).
2. Churchill, M. J. et al. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J. Neurovirol. 12, 146-152 (2006).
3. Johnson, T. P. et al. Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc. Natl Acad. Sci. USA 110, 13588-13593 (2013).
4. Canestri, A. et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin. Infect. Dis. 50, 773-778 (2010).
5. Dahl, V. et al. An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. J. Infect. Dis. 209, 1618-1622 (2014).
6. Peluso, M. J. et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS 26, 1765-1774 (2012).
7. Crooks, A. M. et al. Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies. J. Infect. Dis. 212, 1361-1365 (2015).
8. Churchill, M. J. et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 66, 253-258 (2009).
9. Glass, J. D., Fedor, H., Wesselingh, S. L., McArthur, J. C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38, 755-762 (1995).
10. Gray, L. R. et al. CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latencyreversing agents with implications for cure strategies. Mol. Psychiatry http://dx.doi.org/10.1038/ mp.2015.111 (2015).